Increased Energy & Mobility Losing weight can improve energy levels, reduce joint pain, and enhance overall mobility and quality of life
Administration differences: Like most obesity drugs in this class, retatrutide is a once-weekly subcutaneous injection the same delivery method used by Novo Nordisk's Wegovy (semaglutide), Lilly's Zepbound (tirzepatide), and Novo's CagriSema
[4] [5] By activating GLP-1 receptors, retatrutide is thought to enhance insulin secretion in a glucose-dependent manner, suppress glucagon release, and reduce appetite by acting on satiety centres in the brain
Birth Control Usually No Deferral : Oral contraceptives typically have no impact on plasma donation eligibility
The most common side effects of this class of medication include nausea, vomiting, diarrhea, and loss of appetite
Irregular sleep is one of the top migraine triggers